Cargando…
COVID-19 outcomes in patients taking cardioprotective medications
INTRODUCTION: The coronavirus disease 2019 (COVID-19) caused a worldwide pandemic and has led to over five million deaths. Many cardiovascular risk factors (e.g. obesity or diabetes) are associated with an increased risk of adverse outcomes in COVID-19. On the other hand, it has been suggested that...
Autores principales: | Morrison, Fritha J., Su, Maxwell, Turchin, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550077/ https://www.ncbi.nlm.nih.gov/pubmed/36215288 http://dx.doi.org/10.1371/journal.pone.0275787 |
Ejemplares similares
-
Lifestyle Counseling in Routine Care and Long-Term Glucose, Blood Pressure, and Cholesterol Control in Patients With Diabetes
por: Morrison, Fritha, et al.
Publicado: (2012) -
Following the money: copy-paste of lifestyle counseling documentation and provider billing
por: Zhang, Mary, et al.
Publicado: (2013) -
Performance of Primary Care Physicians and Other Providers on Key Process Measures in the Treatment of Diabetes
por: Morrison, Fritha, et al.
Publicado: (2013) -
Cancer Risk of Patients With Overweight and Obesity: A Predictive Model
por: Turchin, Alexander, et al.
Publicado: (2021) -
Assessment of Sex Disparities in Nonacceptance of Statin Therapy and Low-Density Lipoprotein Cholesterol Levels Among Patients at High Cardiovascular Risk
por: Brown, C. Justin, et al.
Publicado: (2023)